Charles River Laboratories' Q1 Earnings Beat Consensus, Stock Trades Higher On Signs Of Demand Stabilization

benzinga.com/general/health-care/25/05/45261078/charles-river-laboratories-q1-earnings-beat-consensus-stock-trades-higher-on-signs-of-demand-

Charles River Laboratories International Inc (NYSE:CRL) stock is trading higher on Wednesday after the company released better than expected first-quarter 2025 earnings.
The life science tools company reported:
Revenue of $984.2 million, a decrease of 2.7% year over year, beating the…

This story appeared on benzinga.com, 2025-05-07 16:39:29.
The Entire Business World on a Single Page. Free to Use →